|1.||Nath, Chandishwar: 5 articles (03/2014 - 04/2007)|
|2.||Niranjan, Rituraj: 4 articles (03/2014 - 02/2010)|
|3.||Shukla, Rakesh: 4 articles (03/2014 - 02/2010)|
|4.||Shukla, V D: 4 articles (04/2011 - 01/2010)|
|5.||Dave, Alankruta R: 3 articles (04/2011 - 07/2010)|
|6.||Xiao, Dong: 2 articles (01/2013 - 03/2011)|
|7.||Majeed, Muhammed: 2 articles (01/2013 - 03/2011)|
|8.||Zeng, Yan: 2 articles (01/2013 - 03/2011)|
|9.||Mehta, Charmi S: 2 articles (04/2011 - 07/2010)|
|10.||Singh, Shivendra V: 2 articles (03/2011 - 11/2009)|
12/01/2005 - "To evaluate the scientific evidence on guggul for hyperlipidemia including expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing. "
12/01/2005 - "Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration."
08/15/2005 - "Guggulipid use in hyperlipidemia: case report and review of the literature."
12/01/1986 - "Clinical trial of gugulipid--a new hypolipidemic agent of plant origin in primary hyperlipidemia."
01/01/1981 - "Effects of Commiphora Mukul (Guggul) in experimentally induced hyperlipemia and atherosclerosis."
|3.||Memory Disorders (Memory Loss)
04/01/2007 - "Pre-treatment of gugulipid (50 mg/kg, p.o.) daily for 14 days started with the first dose of STZ (ic), significantly prevented STZ (ic)-induced memory deficit. "
04/01/2007 - "Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice."
04/01/2007 - "The study demonstrated that gugulipid has significant protective affect against streptozotocin-induced memory deficits model of dementia that can be attributed to anti-oxidant and anti-AChE activity of gugulipid. "
04/01/2012 - "Clinical efficacy of Shiva Guggulu and Simhanada Guggulu in Amavata (Rheumatoid Arthritis)."
01/01/2011 - "Simhanada Guggulu or Rasona Rasnadi Ghanavati along with Rasona Rasnadi Lepa can be used as an effective ayurvedic intervention in the treatment for rheumatoid arthritis."
01/01/2011 - "A comparative study of Rasona Rasnadi Ghanavati and Simhanada Guggulu on Amavata with special reference to Rheumatoid arthritis."
07/01/2010 - "Clinical effect of Matra Basti and Vatari Guggulu in the management of Amavata (rheumatoid arthritis)."
05/01/2003 - "The authors have conducted both preclinical and clinical investigations of guggul for reduction of pain, stiffness, and improved function, and to determine tolerability in older patients with a diagnosis of OA of the knee. "
12/01/2013 - "In CCI rats, guggulipid (100 and 50 mg/kg) significantly (p < 0.05) reduced the spontaneous pain, mechanical allodynia and mechanical and thermal hyperalgesia responses and the LD50 of guggulipid was 1600 mg/kg. In SNL rats, both doses of guggulipid were found to be ineffective in reversing the spontaneous pain but showing antiallodynic and antihyperalgesic activity. "
12/01/2013 - "Paw withdrawal duration (PWD) to spontaneous pain, chemical allodynia and mechanical hyperalgesia and paw withdrawal latency (PWL) to mechanical allodynia and thermal hyperalgesia were tested before surgery, before and after guggulipid or saline administration (from POD7 to 13) and after the withdrawal of treatment (from POD14 to 20). "
|10.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|2.||Ayurvedic Medicine (Siddha Medicine)